UBE2N expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.352400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.810200E-01
Normal-vs-Stage2
2.964200E-01
Normal-vs-Stage3
2.101000E-01
Normal-vs-Stage4
7.808000E-01
Stage1-vs-Stage2
6.678400E-01
Stage1-vs-Stage3
2.917400E-01
Stage1-vs-Stage4
6.819000E-01
Stage2-vs-Stage3
4.137800E-01
Stage2-vs-Stage4
4.314200E-01
Stage3-vs-Stage4
3.150000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.493600E-01
Normal-vs-AfricanAmerican
6.023200E-01
Normal-vs-Asian
1.184200E-01
Caucasian-vs-AfricanAmerican
8.091000E-01
Caucasian-vs-Asian
1.614040E-01
AfricanAmerican-vs-Asian
3.333600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.255600E-01
Normal-vs-Female
3.649600E-01
Male-vs-Female
5.017800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.756000E-02
Normal-vs-Age(41-60Yrs)
6.175200E-01
Normal-vs-Age(61-80Yrs)
2.551800E-01
Normal-vs-Age(81-100Yrs)
2.187600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.94460000000941E-05
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.780400E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.367200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.032300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.556200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.110000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.057200E-01
Normal-vs-Daily Drinker
1.914560E-01
Normal-vs-Weekly Drinker
1.665450E-01
Normal-vs-Occasional Drinker
8.980800E-01
Normal-vs-Social Drinker
1.751230E-01
Non Drinker-vs-Daily Drinker
9.820000E-01
Non Drinker-vs-Weekly Drinker
9.216800E-01
Non Drinker-vs-Occasional Drinker
4.088100E-02
Non Drinker-vs-Social Drinker
6.112600E-01
Daily Drinker-vs-Weekly Drinker
9.063800E-01
Daily Drinker-vs-Occasional Drinker
5.035700E-02
Daily Drinker-vs-Social Drinker
5.963800E-01
Weekly Drinker-vs-Occasional Drinker
9.110000E-02
Weekly Drinker-vs-Social Drinker
6.789200E-01
Occasional Drinker-vs-Social Drinker
1.373980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.278000E-01
Normal-vs-Grade 2
6.208600E-01
Normal-vs-Grade 3
6.500400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.186000E-01
Grade 1-vs-Grade 3
6.089800E-01
Grade 1-vs-Grade 4
2.278000E-01
Grade 2-vs-Grade 3
5.080800E-01
Grade 2-vs-Grade 4
6.208600E-01
Grade 3-vs-Grade 4
6.500400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.048000E-01
Normal-vs-NonDiabetic
2.736200E-01
Diabetic-vs-NonDiabetic
5.584000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.882300E-02
Normal-vs-NoPancreatitis
2.989200E-01
Pancreatitis-vs-NoPancreatitis
2.317200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.787800E-01
Normal-vs-N1
3.369600E-01
N0-vs-N1
6.774400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.120200E-01
Normal-vs-TP53-NonMutant
3.527600E-01
TP53-Mutant-vs-TP53-NonMutant
5.134200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
